Steroid News and Research

RSS

Exposure to excess hormones in the womb increases risk of heart disease and diabetes

Babies exposed to excess hormones in the womb are not only at increased risk of developing heart disease and diabetes in later life but can pass these risks to their children.

17 Jun 2004

Novel findings on treatments for childhood obesity and early polycystic ovary syndrome (PCOS) in young girls

New research findings presented this week in New Orleans during ENDO 2004, the 86th Annual Meeting of The Endocrine Society, could help keep kids healthier.

16 Jun 2004

What causes polycystic ovary syndrome?

A woman finds herself with excessive facial hair, obesity, menstrual abnormalities, infertility, and enlarged ovaries may have polycystic ovary syndrome (PCOS), an unfortunate condition thought to be caused by excessive secretion by the ovaries of androgen, a hormone associated with male characteristics.

15 Jun 2004

Investigational drug Abraxane is active and well tolerated in women with metastatic breast cancer

Investigational drug Abraxane™ (albumin nanoparticle paclitaxel), administered weekly without steroid premedication, is active and well tolerated in women with metastatic breast cancer whose disease had progressed while they were treated with paclitaxel (Taxol®) and/or docetaxel (Taxotere®).

15 Jun 2004

African-American women less likely to survive breast cancer than white women

A new study led by investigators at Fred Hutchinson Cancer Research Center may help explain why African-American women with breast cancer are more likely to be diagnosed with advanced disease and are less likely to survive the disease than white women.

15 Jun 2004

Seasons may be involved in onset of menopause

Research by Hungarian fertility experts published (Thursday 10 June, 2004) in Europe’s leading reproductive medicine journal Human Reproduction, has revealed that the onset of the menopause may not be dictated only by the fact that a woman’s lifetime supply of eggs are running low, but also by changes in the seasons.

14 Jun 2004

Sirolimus-based therapy following early cyclosporine withdrawal improves transplanted kidney structure and function

Kidney histology and function three years after transplantation are better in kidney-transplant patients who remain on sirolimus-based therapy following early withdrawal of cyclosporine than in patients who continue on this calcineurin inhibitor, according to a new study published in the American Journal of Transplantation.

11 Jun 2004

Cholesterol isn’t all bad

Cholesterol gets lots of bad press, and for good reason. An estimated 24 million women and 18 million men have total cholesterol levels of 240 milligrams per deciliter (mg/dL) or higher increasing their risk of heart attack and stroke.

11 Jun 2004

There are still benefits from hormone therapy after menopause

Despite the highly publicized closing of the Women’s Health Initiative study, the scientific community should not rule out that women may benefit from hormone therapy after menopause, say researchers at UC Davis, Duke and Harvard Universities.

31 May 2004

Anti-inflammatory medicine Roflumilast improved lung function in patients with chronic obstructive pulmonary disease

ALTANA AG’s investigational anti-inflammatory medicine roflumilast improved lung function in patients with Chronic Obstructive Pulmonary Disease (COPD) according to a placebo controlled study presented at the annual meeting of the American Thoracic Society (ATS).

25 May 2004

Once-daily treatment with Alvesco (ciclesonide) in asthma patients has no effect on normal adrenal function

New data presented at the American Thoracic Society’s 2004 International Conference show that once-daily treatment with the investigational therapy Alvesco (ciclesonide) in mild-to-moderate asthma patients has no effect on normal adrenal function, as demonstrated by measurements of the hypothalamic-pituitary-adrenal (HPA)-axis.

24 May 2004

Combination radiation treatment for brain cancer leads to better life

People with cancer that has spread to the brain – about 40 percent of all cancer cases – live longer and enjoy a better quality of life if they are treated with a combination of radiation techniques, according to research conducted, in part, at the James P. Wilmot Cancer Center at the University of Rochester Medical Center.

21 May 2004

Accurate and effective new methods for diagnosis of Inflammatory bowel diseases

Inflammatory bowel diseases collectively cause significant lifestyle sacrifices and suffering and millions of dollars in related health care costs every year, partially due to a lack of effective diagnostic procedures and therapies. In new studies presented today at Digestive Disease Week in New Orleans, researchers show evidence of accurate and effective new methods for diagnosis, as well as improved treatment options, for sufferers of ulcerative colitis and Crohn’s diseases.

19 May 2004

$First drug approved for hormone refractory prostate cancer that has shown a survival benefit$

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

19 May 2004

New method for treating the digestive disease, ulcerative colitis (UC)

Research from Bristol University on a new method for treating the digestive disease, ulcerative colitis (UC) will be presented at an international conference of experts in New Orleans on Tuesday, 18 May as part of Digestive Disease Week 2004.

19 May 2004

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004

Connetics issued U.S. patent for emollient-foam technology

Connetics Corporation, a specialty pharmaceutical company that develops and commercializes dermatology products, announced today that on May 4, 2004 the United States Patent and Trademark Office (USPTO) issued to Connetics Patent No. 6,730,288 B1. The patent has 7 independent product claims, and covers a pharmaceutical aerosol foam composition having occlusive capability.

17 May 2004

Influenza vaccine does provide protection against influenza in most asthma patients taking inhaled steroids

The influenza vaccine protected asthma patients who use inhaled steroids against type A flu, although its protection against type B flu was significantly reduced in those taking high doses of inhaled steroids, said a researcher from Baylor College of Medicine in a recent publication.

15 May 2004

New designer steroid discovered in anonymously provided syringe

A previously unknown synthetic "designer" steroid has been identified as tetrahydrogestrinone (THG). Researchers working out of the UCLA Olympic Analytical Laboratory in Los Angeles synthesized and characterized the "New Chemical Entity", and proceeded to develop a rapid and accurate urine detection test for it.

14 May 2004

Risk of prostate cancer greater in men over 50 with high levels of testosterone

Men over 50 years of age with high blood levels of testosterone have an increased risk of prostate cancer, according to a study by researchers at Johns Hopkins and the National Institute on Aging. The finding throws some doubt on the safety of testosterone replacement therapy, the investigators say.

11 May 2004

Steroid News and Research

Exposure to excess hormones in the womb increases risk of heart disease and diabetes

Novel findings on treatments for childhood obesity and early polycystic ovary syndrome (PCOS) in young girls

What causes polycystic ovary syndrome?

Investigational drug Abraxane is active and well tolerated in women with metastatic breast cancer

African-American women less likely to survive breast cancer than white women

Seasons may be involved in onset of menopause

Sirolimus-based therapy following early cyclosporine withdrawal improves transplanted kidney structure and function

Cholesterol isn’t all bad

There are still benefits from hormone therapy after menopause

Anti-inflammatory medicine Roflumilast improved lung function in patients with chronic obstructive pulmonary disease

Once-daily treatment with Alvesco (ciclesonide) in asthma patients has no effect on normal adrenal function

Combination radiation treatment for brain cancer leads to better life

Accurate and effective new methods for diagnosis of Inflammatory bowel diseases

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

New method for treating the digestive disease, ulcerative colitis (UC)

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Connetics issued U.S. patent for emollient-foam technology

Influenza vaccine does provide protection against influenza in most asthma patients taking inhaled steroids

New designer steroid discovered in anonymously provided syringe

Risk of prostate cancer greater in men over 50 with high levels of testosterone

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News